Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,170 public trials 550 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment

NCT00537407

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Scripps Clinic Liver Disease Research Center La Jolla, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Miami Center for Liver Diseases Miami, Florida, United States
  • The Johns Hopkins University School of Medicine Baltimore, Maryland, United States
View Trial Details
Completed

A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients

NCT00854802

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • UZ Gent Ghent, Belgium
  • C.H.U - Hôpital Henri-Mondor Créteil, France
  • C.H.U de Lyon Hôpital de l'Hôtel Dieu Lyon, France
View all 40 locations
View Trial Details
Completed

T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents

NCT00022763

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Children's Hosp Los Angeles Los Angeles, California, United States
  • Univ of Florida Gainesville Gainesville, Florida, United States
  • New York Hosp - Cornell / Program for Children with AIDS New York, United States
  • Mount Sinai Hosp New York, United States
View Trial Details
Completed

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

NCT01728324

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • 1241.36.00016 Boehringer Ingelheim Investigational Site North Little Rock, Arkansas, United States
  • 1241.36.00020 Boehringer Ingelheim Investigational Site Anaheim, California, United States
  • 1241.36.00005 Boehringer Ingelheim Investigational Site Bakersfield, California, United States
  • 1241.36.00009 Boehringer Ingelheim Investigational Site La Jolla, California, United States
View all 109 locations
View Trial Details
Completed

Epidemiological Study to Evaluate the Management of Patients With Chronic Hepatitis C and Previous Treatment Failure

NCT01033045

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • H. de Antequera Antequera, Andalusia, Spain
  • H. Puerta de Mar Cadiz, Andalusia, Spain
  • H. Puerto Real Cadiz, Andalusia, Spain
  • H. Vírgen de las Nieves Granada, Andalusia, Spain
View all 104 locations
View Trial Details

Related conditions